Tianmushan Pharmaceutical Overview
- Year Founded
-
1958
- Status
-
Public
- Employees
-
392
- Stock Symbol
-
600671
- Investments
-
4
- Share Price
-
$2.39
- (As of Monday Closing)
Tianmushan Pharmaceutical General Information
Description
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.
Contact Information
Website
www.hztmyy.comCorporate Office
- Room 1803, Boya Times Building
- Xiaoshan District
- Hangzhou, Zhejiang
- China
Corporate Office
- Room 1803, Boya Times Building
- Xiaoshan District
- Hangzhou, Zhejiang
- China
Tianmushan Pharmaceutical Stock Performance
As of 16-Nov-2026, Tianmushan Pharmaceutical’s stock price is $2.39. Its current market cap is $292M with 122M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.39 | $2.52 | $2.32 - $3.62 | $292M | 122M | 2.98M | $0.01 |
Tianmushan Pharmaceutical Financials Summary
As of 30-Sep-2026, Tianmushan Pharmaceutical has a trailing 12-month revenue of $29.4M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 417,060 | 328,373 | 160,814 | 204,174 |
| Revenue | 29,393 | 29,446 | 30,283 | 17,213 |
| EBITDA | 2,613 | 5,829 | 7,353 | (2,011) |
| Net Income | 1,671 | 2,451 | 2,125 | (5,410) |
| Total Assets | 62,860 | 63,177 | 60,474 | 48,851 |
| Total Debt | 23,703 | 23,762 | 20,656 | 16,190 |
Tianmushan Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tianmushan Pharmaceutical Signals
Tianmushan Pharmaceutical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tianmushan Pharmaceutical Investments & Acquisitions (4)
Tianmushan Pharmaceutical’s most recent deal was a Merger/Acquisition with Sanshentai Clinic for . The deal was made on 13-Oct-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sanshentai Clinic | 13-Oct-2017 | Merger/Acquisition | Clinics/Outpatient Services | ||
| Anhui Dechang Pharmaceutical | 27-Jun-2017 | Merger/Acquisition | Pharmaceuticals | ||
| Liaoning Cotech Bio Gen Pharmaceutical | 15-Dec-2015 | Merger/Acquisition | Pharmaceuticals | ||
| Huangshan Tianmu Mint Pharmaceutical Company | 01-Dec-2006 | Joint Venture | Pharmaceuticals |
Tianmushan Pharmaceutical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Tianmushan Pharmaceutical Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sanshentai Clinic | Hangzhou, China | 2014 |
Tianmushan Pharmaceutical FAQs
-
When was Tianmushan Pharmaceutical founded?
Tianmushan Pharmaceutical was founded in 1958.
-
Where is Tianmushan Pharmaceutical headquartered?
Tianmushan Pharmaceutical is headquartered in Hangzhou, China.
-
What is the size of Tianmushan Pharmaceutical?
Tianmushan Pharmaceutical has 392 total employees.
-
What industry is Tianmushan Pharmaceutical in?
Tianmushan Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Tianmushan Pharmaceutical a private or public company?
Tianmushan Pharmaceutical is a Public company.
-
What is Tianmushan Pharmaceutical’s stock symbol?
The ticker symbol for Tianmushan Pharmaceutical is 600671.
-
What is the current stock price of Tianmushan Pharmaceutical?
As of 16-Nov-2026 the stock price of Tianmushan Pharmaceutical is $2.39.
-
What is the current market cap of Tianmushan Pharmaceutical?
The current market capitalization of Tianmushan Pharmaceutical is $292M.
-
What is Tianmushan Pharmaceutical’s current revenue?
The trailing twelve month revenue for Tianmushan Pharmaceutical is $29.4M.
-
What is Tianmushan Pharmaceutical’s annual earnings per share (EPS)?
Tianmushan Pharmaceutical’s EPS for 12 months was $0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process